DHC Delivers Strong Q2 2026 Results, Reaffirms Raised Guidance with Improved Leverage
DHC has more than doubled off its 52-week low of $3.18.
Summary
DHC posted strong Q2 2026 results with 37.2% same-property SHOP NOI growth and improved leverage, while reaffirming raised full-year guidance but with slightly reduced occupancy and revenue growth assumptions.
Key Events · Earnings and Guidance · DHC
-
Q2 2026 Results Beat
Same-property SHOP NOI grew 37.2% YoY to $52.0M; consolidated NOI rose 20.4% to $84.4M; Normalized FFO of $38.9M ($0.16/share) vs $18.6M a year ago.
-
Full-Year Guidance Reaffirmed with Tweaks
Reaffirmed raised 2026 guidance (Normalized FFO $0.56-$0.62) but lowered mid-point same-property SHOP occupancy growth to 200 bps (from 300 bps) and revenue growth to 6.6% (from 8.0%), while reducing expense growth to 2.5% (from 4.5%).
-
Balance Sheet Strengthened
Net debt to annualized Adjusted EBITDAre improved to 7.1x from 7.8x last quarter and 8.7x a year ago; total liquidity of $266.8M with $116.8M cash and $150M undrawn credit facility.
-
Robust Leasing Activity
Leased 477,000 sq ft in Medical Office/Life Science portfolio at rents 6.7% higher than prior, with a 7.1-year weighted average lease term; same-property occupancy rose to 95.8%.
Analysis · DHC · Real Estate & Construction
Diversified Healthcare Trust delivered a strong second quarter, with same-property SHOP NOI surging 37.2% year-over-year and consolidated NOI up 20.4%. The company reaffirmed its full-year 2026 guidance, which was raised in June, but tempered some underlying assumptions—reducing expected occupancy growth to 200 bps from 300 bps and revenue growth to 6.6% from 8.0%, while also lowering expense growth forecasts. The balance sheet continued to strengthen, with net debt to annualized Adjusted EBITDAre improving to 7.1x from 7.8x last quarter. The results underscore operational momentum from operator transitions, but the guidance tweaks suggest a more conservative outlook on occupancy gains. For a REIT with a market cap around $2.1 billion, the magnitude of NOI growth and leverage improvement is notable, though the mixed guidance revisions keep this from being a thesis-altering event.
At the time of this filing, DHC was trading at $8.59 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $3.18 to $9.66. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.